CBMG is a New York-based biopharmaceutical company that develops cell therapies for the treatment of cancer and degenerative diseases.
Business Model:
Revenue: $322.9k
Employees: 51-200
Address: 9605 Medical Center Drive
City: Rockville
State: MD
Zip: 20850
Country: US
CBMG is a New York-based biopharmaceutical company that develops cell therapies for the treatment of cancer and degenerative diseases.
Contact Phone:
+13018255320
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/18/2014
Ticker Symbol:
CBMG
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2021 | Series A | $0 |
AstraZeneca GIC Sequoia Capital China TF Capital YF Capital AstraZeneca GIC Sequoia Capital China TF Capital YF Capital |
7/2013 | Post-IPO Equity | $3M | 4/2014 | Post-IPO Equity | $6.9M | 12/2013 | Equity | $6.9M | 12/2017 | Private Placement | $14.5M | 1/2018 | Private Equity Round | $30.6M |
Sailing Capital Overseas Investment Ltd |
2/2018 | Post-IPO Equity | 1 | $30.6M |
Sailing Capital Sailing Capital |
2/2016 | Post-IPO Equity | 1 | $43.1M |
Wuhan Dangdai Science &a; Technology Industries Group Wuhan Dangdai Science &a; Technology Industries Group |
9/2021 | Series A | 5 | $120M |
Sequoia Capital China Yunfeng Capital GIC TF Capital AstraZeneca GIC Sequoia Capital China TF Capital YF Capital |
---|
Announced Date | Name | Price |
---|---|---|
8/2014 | Agreen Biotech |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|